Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Corn could be key to saving your eyesight

NCT ID NCT02113254

First seen May 25, 2026 · Last updated Jun 20, 2026 · Updated 9 times

Summary

This study looked at whether eating corn rich in zeaxanthin (a natural pigment) could increase the density of the macular pigment in the eye, which may help prevent age-related macular degeneration (AMD), a leading cause of blindness. Nine healthy volunteers aged 20-35 ate a daily serving of this corn for 10 weeks. The goal was to measure changes in macular pigment density and blood zeaxanthin levels.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGE MACULAR DEGENERATION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CHU de Bordeaux

    Bordeaux, 33000, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

corn with high zeaxanthin content

What this could lead to

If it works, this could point toward a simple dietary strategy to help prevent age-related macular degeneration.

What could go wrong

This was a very small, early study with only 9 healthy volunteers, and it was terminated early. Results may not apply to older adults or those with the disease.

Conditions

The condition(s) this trial relates to.

age-related macular degeneration Callosities

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.